Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Streptozocin

Generic Name: Streptozocin

Brand Names: Zanosar

Drug Type: Small Molecule

Chemical Formula: C_₈H_₁₅N_₃O_₇

CAS Number: 66395-18-4

Unique Ingredient Identifier: 8H27GUR065

Overview

An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals.

Background

An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals.

Indication

For the treatment of malignant neoplasms of pancreas (metastatic islet cell carcinoma).

Associated Conditions

Metastatic Islet Cell Carcinoma

Clinical Trials

Two Chemotherapy Regimens Plus or Minus Bevacizumab

Phase 2

Active, not recruiting

Posted: 2017/11/22

Sponsor:Gustave Roussy, Canc...

ID:NCT03351296

Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors

Phase 2

Terminated

Posted: 2008/02/07

Sponsor:H. Lee Moffitt Cance...

ID:NCT00609765

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

Phase 2

Completed

Posted: 2008/01/28

Sponsor:Cambridge University...

ID:NCT00602082

A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.

Phase 2

Completed

Posted: 2007/03/16

Sponsor:Hoffmann-La Roche

ID:NCT00448136

Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)

Phase 3

Completed

Posted: 2004/10/20

Sponsor:

Collaborative Group ...

ID:NCT00094497

FDA Approved Products

Zanosar

Manufacturer:ESTEVE PHARMACEUTICALS, S.A.

Route:INTRAVENOUS

Strength:1 g in 10 mL

Approved: 2023/04/03

NDC:68118-100

Zanosar

Manufacturer:Teva Parenteral Medicines, Inc.

Route:INTRAVENOUS

Strength:100 mg in 1 mL

Approved: 2023/06/29

NDC:0703-4636

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy

Drug Development Updates

Streptozocin

Overview

Background

Indication

Associated Conditions

Clinical Trials

FDA Approved Products

Singapore Approved Products

Related News

Genprex's Reqorsa Advances in Phase 2 Trial for Small Cell Lung Cancer

Drug Development Updates